SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): ~~October~~August 1330, ~~2011~~2013

BioMedical Technology Solutions Holdings, Inc.

(Exact name of registrant as specified in its charter)

Colorado

____000-52652___

26-3161860

(State or other jurisdiction of

incorporation or organization)

(Commission

file number)

(IRS Employer

Identification No.)

~~12741~~P ~~East~~O ~~Caley~~Box ~~Avenue, Unit 140 Centennial, CO 80111 (Address of principal executive offices) (Zip Code)~~2503

~~Registrant's~~ Fort ~~telephone number~~Lauderdale, ~~including area code:~~FL ~~(303) 653-0100~~33303

~~9800~~ (Address Mtof ~~Pyramid~~principal ~~Court~~executive #offices) (Zip ~~250, Englewood, CO 80112~~Code)

Registrant's telephone number, including area code: (954) 275-3309

9800 Mt Pyramid Court # 350

Englewood, CO 80112

(Former name or former address, if changed since last report)


___	Written communications pursuant to Rule 425 under the Securities Act
___	Soliciting material pursuant to Rule 14a-12 under the Exchange Act
___	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
___	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

ITEM 41.01 ~~CHANGE~~ENTRY ININTO ~~REGISTRANT’S~~A ~~CERTIFYING~~MATERIAL ~~ACCOUNTANT~~DEFINITIVE AGREEMENT

OnEffective ~~October~~August 1330, ~~2011~~2013, ~~the~~ ~~Public~~BioMedical ~~Company~~Technology ~~Audit~~Solutions ~~Oversight~~Holdings, ~~Board~~Inc., a Colorado corporation (~~"PCAOB"~~the “Company” or “BMTS”) ~~announced~~(OTC ~~that~~Pink: BMTL) itentered ~~had~~into ~~revoked~~an ~~the~~Agreement ~~registration~~and Plan of ~~Cordovano~~Merger ~~and~~(“Merger ~~Honeck~~Agreement”), ~~LLP,~~between the Company's ~~prior~~and ~~independent~~MedClean ~~registered~~Technologies, ~~accountants~~Inc. As, a Delaware corporation (“MedClean”) (OTC Pink: MCLN). The Merger Agreement, if consummated, would result ofin ~~that~~BMTS ~~revocation~~merging with and into MedClean, with MedClean being the ~~Company~~surviving ~~can~~corporation no(the ~~longer~~“Merger”) ~~include~~with BMTS’s existing subsidiary, BioMedical Technology Solutions, Inc. (“BMTS Sub) surviving as a wholly owned subsidiary of MedClean. Upon consummation of the ~~audit~~Merger, all ~~reports~~issued and ~~consents~~outstanding shares of ~~that~~BMTS ~~firm~~common instock ~~its~~will ~~filings~~convert into a number of shares of MedClean common stock which will represent, when issued, and ~~other~~after ~~reports~~giving ~~with~~effect to the ~~SEC. In~~Debt ~~light~~Conversions described below, 60% of the ~~foregoing~~total ~~actions~~issued byand ~~the~~outstanding ~~PCAOB,~~shares of MedClean (the ~~Company~~“Exchange ~~deems~~Ratio”). The ~~that~~Merger ~~Cordovano~~will ~~and~~result ~~Honeck,~~in ~~LLP~~a ~~has~~change ~~resigned~~in ascontrol of MedClean. The Merger is subject to dissenters’ rights of the ~~Company~~BMTS ~~independent~~and ~~registered~~MedClean ~~accountants~~shareholders.

~~Cordovano~~Consummation ~~and~~of ~~Honeck,~~the ~~LLP~~acquisition is subject to the satisfaction of numerous conditions, ~~issued~~including an(i) ~~audit~~MedClean ~~report~~filing onall ~~our~~delinquent ~~financial~~reports ~~statements~~under asSection 13(a) of ~~and~~the ~~for~~Securities ~~the~~Exchange ~~years~~Act ~~ended~~of ~~December~~1934, 31as amended, ~~2008~~(“Exchange Act”), ~~2009~~including audited and ~~2010. The~~interim financial statements, as(ii) ofBMTS ~~and~~completing ~~for~~ the preparation of two years ~~ending~~audited ~~December~~financial ~~2009~~statements ~~and~~complying ~~2010~~with ~~included~~Regulation anS-X ~~explanatory~~under ~~paragraph~~the ~~concerning~~Exchange Act, (iii) both MedClean and BMTS obtaining the ~~Company’s~~agreements ~~ability~~of their respective creditors to ~~continue~~convert assubstantially aall ~~going~~outstanding ~~concern.~~liabilities Into ~~the~~shares ~~period~~of ~~from~~common ~~Cordovano~~stock ~~and~~(the ~~Honeck~~“Debt Conversions”), ~~LLP’s~~which ~~appointment~~Debt ~~until~~Conversions ~~October~~will ~~13,~~be ~~2011~~given effect prior to determining the Exchange Ratio, (iv) the ~~date~~approval of ~~resignation),~~the ~~there~~Merger ~~were~~by nothe ~~disagreements~~shareholders ~~with~~of ~~Cordovano~~both BMTS and ~~Honeck~~MedClean, ~~LLP~~(v) onthe ~~any~~preparation ~~matters~~and effectiveness of ~~accounting~~a ~~principles~~Registration orStatement ~~practices,~~on ~~financial~~Form ~~statement~~S-4 ~~disclosure,~~registering orfor ~~auditing~~sale ~~scope~~under ~~and~~the ~~procedures~~Securities ~~which~~Act of 1933, ifas ~~not~~amended ~~resolved~~(the to“Securities Act”) the ~~satisfaction~~shares of ~~Cordovano~~MedClean ~~and~~common ~~Honeck,~~stock ~~LLP,~~issuable ~~would~~to ~~have~~the ~~caused~~BMTS ~~Cordovano~~shareholders ~~and~~in ~~Honeck~~the Merger, ~~LLP~~(vi) subject to ~~make~~certain ~~reference~~rights toas ~~the~~set ~~matter~~forth in ~~its~~the ~~report~~Merger Agreement, no shareholder of ~~the~~either ~~financial~~BMTS ~~statements;~~or MedClean exercising statutory dissenters’ rights, (vii) complete and ~~there~~satisfactory ~~were~~due nodiligence ~~reportable~~and ~~events~~other asconditions ~~defined~~customary in ~~Item~~transactions ~~304(a)~~of ~~(3)~~this ofnature. There ~~Regulation~~can ~~S-K~~be no assurance as to when the transaction can or will be consummated. A copy of the Merger Agreement is filed herewith as Exhibit 2.1

~~Effective~~Concurrently ~~November 18, 2011 the Company’s Board of Directors,~~ with the ~~concurrence~~execution of the ~~Audit~~Merger ~~Committee~~Agreement, ~~approved~~BMTS ~~the~~and ~~appointment~~MedClean ofentered ~~Malone~~into ~~Bailey,~~a ~~LLP~~Management toAgreement ~~serve~~(“Management asAgreement”), ~~the~~whereby ~~Company’s~~pending ~~independent accountant to audit~~ the ~~Company’s~~closing ~~financial~~of ~~statements. Prior to its engagement as~~ the ~~Company's~~Merger ~~independent~~described ~~accountant~~above, ~~the~~BMTS ~~Company~~has ~~had~~been ~~not~~retained ~~consulted~~as ~~Malone~~Business ~~Bailey,~~Manager ~~LLP~~of ~~with~~MedClean ~~respect~~ to perform the ~~application~~day ~~of accounting principles~~ to ~~specific~~day ~~transactions~~business oroperations ~~the type~~ of ~~audit opinion that might be rendered on the Company's financial statements~~MedClean. A ~~The~~copy ~~engagement~~ of ~~Malone~~the ~~Bailey,~~Management ~~LLP~~Agreement ~~was~~is ~~effective~~filed onherewith ~~November~~as ~~18,~~Exhibit ~~2011~~10.1.

ITEM 9.01: FINANCIAL STATEMENTS AND EXHIBITS


	(c)	Exhibits

	Item	Title

	2.1	Agreement and Plan of Merger dated effective August 30, 2013
	10.1	Management Agreement dated September 3, 2013.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS, INC. Date: ~~November~~September 225, ~~2011~~2013 By: __/s/ Gex F.Richardson________ ~~Richardson __~~ Gex F. Richardson, President

Filing Compare · BIOMEDICAL TECHNOLOGY SOLUTIONS HOLDINGS INC